Knobbe Martens Olson & Bear is pleased to announce that Christopher T. Sweeney, an associate of the firm, recently moved from the firm’s San Diego office to the Seattle office….

Joseph R. Re, a partner of Knobbe Martens Olson & Bear, was installed as President of the Federal Circuit Bar Association (FCBA) at the organization’s recent 10th Annual Bench &…

William Zimmerman Managing Partner D.C., Knobbe Martens As a fourth-year associate, the honors Harvard Law School grad landed his firm the multimillion-dollar fight for Ranbaxy Laboratories Ltd. over the generic…

Knobbe Martens Olson & Bear LLP announced today that the U.S. Court of Appeals for the Federal Circuit ruled in favor of its client – Industrial Dynamics Co. Ltd. –…

Ranbaxy will Market Generic Atorvastatin in the U.S. with 180 Days Exclusivity from Nov. 30, 2011 – Agreement Also Resolves Caduet, Accupril Litigation in the U.S. Ranbaxy Laboratories Limited (Ranbaxy), …

Knobbe Martens Olson & Bear LLP, one of the largest intellectual property law firms in the United States, has consistently ranked as the top law firm, obtaining the most patents…

Knobbe Martens Olson & Bear LLP, one of the largest intellectual property law firms in the United States, is currently ranked among the top 5% out of 328 firms in…

Knobbe Martens, one of the largest intellectual property law firms in the United States with offices throughout California, and in Washington D.C. and Seattle, ranked third nationally for the highest…

John M. Carson, a partner with the leading intellectual property law firm, Knobbe Martens Olson & Bear, was recently elected as President of the International Technology Law Association (ITechLaw). Previously,…

Knobbe Martens announced this week that its client, India-based generic pharmaceutical company Ranbaxy Laboratories, has settled its patent infringement lawsuit against AstraZeneca, producer of the blockbuster ulcer drug, Nexium. The…